CBLN4

 

Full name: cerebellin 4 precursor Alias Symbol: dJ885A10.1
Type: protein-coding gene Cytoband: 20q13.2
Entrez ID: 140689 HGNC ID: HGNC:16231 Ensembl Gene: ENSG00000054803 OMIM ID: 615029
Drug and gene relationship at DGIdb

 

Expression of CBLN4:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 CBLN4 140689 234024_at -0.0625 0.8706
GSE26886 CBLN4 140689 234024_at -0.0302 0.7960
GSE45670 CBLN4 140689 234024_at 0.0037 0.9800
GSE53622 CBLN4 140689 86678 0.2042 0.0357
GSE53624 CBLN4 140689 86678 0.2871 0.0007
GSE63941 CBLN4 140689 234024_at 0.0158 0.9306
GSE77861 CBLN4 140689 234024_at -0.3103 0.0072
GSE97050 CBLN4 140689 A_33_P3385516 0.0945 0.6782
TCGA CBLN4 140689 RNAseq 0.0373 0.9614

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by CBLN4 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of CBLN4:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 CBLN4 140689 15 1 14
GSE20123 CBLN4 140689 15 1 14
GSE43470 CBLN4 140689 13 0 30
GSE46452 CBLN4 140689 29 0 30
GSE47630 CBLN4 140689 24 1 15
GSE54993 CBLN4 140689 0 17 53
GSE54994 CBLN4 140689 27 0 26
GSE60625 CBLN4 140689 0 0 11
GSE74703 CBLN4 140689 11 0 25
GSE74704 CBLN4 140689 12 0 8
TCGA CBLN4 140689 44 4 48

Total number of gains: 190; Total number of losses: 24; Total Number of normals: 274.  


 

Somatic mutations of CBLN4:

 

Generating mutation plots.

 

Highly correlated genes for CBLN4:

 

Showing top 20/404 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
CBLN4CCDC420.781536303
CBLN4RIPK40.767011303
CBLN4GUCY2C0.766426303
CBLN4VGLL20.733607303
CBLN4KRT350.726062303
CBLN4RETN0.721962303
CBLN4MTUS2-AS10.713278303
CBLN4MAST40.707858303
CBLN4PTK60.707705303
CBLN4PKLR0.706903303
CBLN4SHISA70.704187303
CBLN4CCL250.7028404
CBLN4EPS8L20.700991303
CBLN4CACNA1G0.699652404
CBLN4TERT0.694156403
CBLN4FAM189A20.691827303
CBLN4YIPF10.688793303
CBLN4BBOX10.688766303
CBLN4HCG90.688704303
CBLN4GALR30.687633403

For details and further investigation, click here